Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Cambrex Corp (CBM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 1,749,419
  • Shares Outstanding, K 32,730
  • Annual Sales, $ 490,640 K
  • Annual Income, $ 81,680 K
  • 36-Month Beta 2.28
  • Price/Sales 3.58
  • Price/Cash Flow 15.12
  • Price/Book 3.72

Price Performance

See More
Period Period Low Period High Performance
1-Month
51.55 unch
on 10/17/17
57.30 -10.03%
on 10/05/17
-2.05 (-3.82%)
since 09/15/17
3-Month
48.70 +5.85%
on 09/08/17
62.30 -17.26%
on 08/03/17
-6.90 (-11.80%)
since 07/17/17
52-Week
38.30 +34.60%
on 11/03/16
62.95 -18.11%
on 05/04/17
+10.75 (+26.35%)
since 10/17/16

Most Recent Stories

More News
Cambrex Invests in Generic API Development and Manufacturing Capabilities at Its Milan Site

Cambrex Corporation (NYSE:CBM), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced that it has made a number of investments, in both...

CBM : 51.60 (-3.46%)
Tecan initiates succession process for the Board of Directors

Tecan Group AG / Tecan initiates succession process for the Board of Directors . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement....

NVIV : 1.48 (-1.33%)
TCHBF : 191.0000 (unch)
OSIR : 4.3400 (+0.70%)
PKI : 70.41 (-1.18%)
CBM : 51.60 (-3.46%)
Cambrex Opens Large Scale API Manufacturing Facility and Invests in Supporting Waste Water Treatment Plant at Its Karlskoga, Sweden Site

Cambrex Corporation (NYSE:CBM), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced that it has completed the installation of new,...

CBM : 51.60 (-3.46%)
Is Cambrex Corporation (CBM) a Suitable Value Stock?

Cambrex Corporation (CBM) appears to be a good choice for value investors right now, given its favorable metrics and estimate revisions.

CBM : 51.60 (-3.46%)
Cambrex to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference

Cambrex Corporation (NYSE:CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced that Steven Klosk, President and Chief Executive...

CBM : 51.60 (-3.46%)
Cambrex Invests In New Analytical Development And Method Validation Laboratory At Its High Point, NC Facility

Cambrex Corporation (NYSE: CBM), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced that it is expanding its High Point, NC facility...

CBM : 51.60 (-3.46%)
Cambrex to Present at Upcoming Investor Conferences in September

Cambrex Corporation (NYSE:CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced that company management will present at the following...

WFC : 53.35 (-0.84%)
CBM : 51.60 (-3.46%)
Cambrex Invests in New Analytical Development and Method Validation Laboratory at Its High Point, NC Facility

Cambrex Corporation (NYSE:CBM), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced that it is expanding its High Point, NC facility...

CBM : 51.60 (-3.46%)
Shares of Cambrex Corp Rank the Highest in Terms of Relative Performance in the Life Sciences Tools & Services Industry (CBM, TMO, INCR, PRAH, CRL)

Here are the top 5 stocks in the Life Sciences Tools & Services industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were...

INCR : 54.50 (-2.24%)
TMO : 188.63 (-1.39%)
PRAH : 82.05 (-1.58%)
CRL : 114.14 (+0.06%)
CBM : 51.60 (-3.46%)
Cambrex Surpasses ChemStewards® Requirements and Qualifies for SOCMA's "Excellence" Ranking

Cambrex Corporation (NYSE: CBM), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced that as a result of exceeding key performance...

CBM : 51.60 (-3.46%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More

Business Summary

Cambrex Corporation manufactures and markets a broad line of specialty chemicals and commodity chemical intermediates and also manufactures chemicals to customer specifications. There are five product categories: pharmaceutical bulk actives; pharmaceutical intermediates; organic intermediates; performance...

See More

Support & Resistance

2nd Resistance Point 54.58
1st Resistance Point 54.02
Last Price 51.60
1st Support Level 53.12
2nd Support Level 52.78

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart